mail
versión imprimible
 
 

6th Microbiome Movement - Drug Development Summit Europe

Evvnt Promotion / evvnt
-
25.01.2022 - 27.01.2022  The Tower Hotel, St Katharine's Way, E1W 1LD Greater London, England, United Kingdom
Time: 10:00 to 17:50
 
Temas de la conferencia
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/919896-3?pid=4832

Speakers: Charles Bundinof, Strain Discovery and Microbiome Science Lead, IFF, Denise Kelly, Investment Advisor, Seventure, Duncan Peyton, CEO, 4D Pharma PLC, and more.
 

Información e inscripción:

https://go.evvnt.com/919896-2?pid=4832
Ms. Emily Lincoln
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
Drug Developer - Conference Only: GBP 2049.00, Academic - Conference Only: GBP 1649.00, Solution and Service Provider - Conference Only: GBP 2699.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

European Public Health Association (EUPHA)Center of ExcellenceSwiss Tropical and Public Health InstituteÖsterreichisches Rotes KreuzÄrztekammer für WienHilfswerk AustriaOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Österreichische Gesellschaft für Public Health